Literature DB >> 24112779

Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.

Jiwei Huang1, Xiaoying Yao, Jin Zhang, Baijun Dong, Qi Chen, Wei Xue, Dongming Liu, Yiran Huang.   

Abstract

MicroRNAs (miRNAs), which negatively regulate protein expression by binding protein-coding mRNAs, have been integrated into cancer development and progression as either oncogenes or tumor suppressor genes. miR-30c was reported to be downregulated in several types of cancer. However, its role in human renal cell carcinoma (RCC) remains largely unknown. Here, we show that miR-30c is significantly downregulated in human RCC tissues and cell lines. We found that miR-30c downregulation could be induced by hypoxia in RCC cells in a hypoxia-inducible factors (HIFs) dependent manner. Repression of miR-30c through its inhibitor resulted in reduction of E-cadherin production and promotion of epithelial-mesenchymal transition (EMT), while overexpression of miR-30c inhibited EMT in RCC cells. We identified Slug as a direct target of miR-30c in RCC cells. Slug was upregulated in RCC tissues and its expression could be induced by hypoxia, which is consistent with downregulation of miR-30c by hypoxia. Forced overexpression of Slug in 786-O cells reduced E-cadherin production, and promoted EMT as well as cell migration. Moreover, Slug overexpression abrogated the inhibitory role of miR-30c in regulating EMT and cell migration, indicating miR-30c regulates EMT through Slug in RCC cells. Our findings propose a model that hypoxia induces EMT in RCC cells through downregulation of miR-30c, which leads to subsequent increase of Slug expression and repression of E-cadherin production, and suggest a potential application of miR-30c in RCC treatment.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24112779      PMCID: PMC7653518          DOI: 10.1111/cas.12291

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  31 in total

1.  Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.

Authors:  Annika C Russ; Sandrine Sander; Sonja C Lück; Katharina M Lang; Marion Bauer; Frank G Rücker; Hans A Kestler; Richard F Schlenk; Hartmut Döhner; Karlheinz Holzmann; Konstanze Döhner; Lars Bullinger
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

2.  miR-21 and miR-214 are consistently modulated during renal injury in rodent models.

Authors:  Laura Denby; Vasudev Ramdas; Martin W McBride; Joe Wang; Hollie Robinson; John McClure; Wendy Crawford; Ruifang Lu; Dianne Z Hillyard; Raya Khanin; Reuven Agami; Anna F Dominiczak; Claire C Sharpe; Andrew H Baker
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

Review 3.  The EMT regulator slug and lung carcinogenesis.

Authors:  Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

4.  Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.

Authors:  Xiaofang Xu; Renbing Jia; Yixiong Zhou; Xin Song; Jing Wang; Guanxiang Qian; Shengfang Ge; Xianqun Fan
Journal:  Int J Oncol       Date:  2011-03-03       Impact factor: 5.650

5.  MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.

Authors:  F Germán Rodríguez-González; Anieta M Sieuwerts; Marcel Smid; Maxime P Look; Marion E Meijer-van Gelder; Vanja de Weerd; Stefan Sleijfer; John W M Martens; John A Foekens
Journal:  Breast Cancer Res Treat       Date:  2010-05-19       Impact factor: 4.872

Review 6.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

Review 7.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.

Authors:  C M Goparaju; J D Blasberg; S Volinia; J Palatini; S Ivanov; J S Donington; C Croce; M Carbone; H Yang; H I Pass
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

Review 9.  Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers.

Authors:  Catarina Castro Alves; Fatima Carneiro; Heinz Hoefler; Karl-Friedrich Becker
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.

Authors:  Yong-Jun Liang; Qiu-Yu Wang; Ci-Xiang Zhou; Qian-Qian Yin; Ming He; Xiao-Ting Yu; Dan-Xia Cao; Guo-Qiang Chen; Jian-Rong He; Qian Zhao
Journal:  Carcinogenesis       Date:  2012-12-17       Impact factor: 4.944

View more
  36 in total

Review 1.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

2.  Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.

Authors:  Jiwei Huang; Xiaoying Yao; Jin Zhang; Baijun Dong; Qi Chen; Wei Xue; Dongming Liu; Yiran Huang
Journal:  Cancer Sci       Date:  2013-10-27       Impact factor: 6.716

Review 3.  The epigenetic landscape of renal cancer.

Authors:  Mark R Morris; Farida Latif
Journal:  Nat Rev Nephrol       Date:  2016-11-28       Impact factor: 28.314

4.  Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells.

Authors:  C Lin; Y Wang; Y Wang; S Zhang; L Yu; C Guo; H Xu
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

Review 5.  Current Concepts of Epigenetics in Testicular Cancer.

Authors:  Alfredo Harb-De la Rosa; Meenakkshy Manoharan; Ahmed Saeed Goolam
Journal:  Indian J Surg Oncol       Date:  2017-01-13

6.  miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.

Authors:  Lu Jin; Yifan Li; Zeng Zhang; Tao He; Jia Hu; Jiaju Liu; Mingwei Chen; Yaoting Gui; Shangqi Yang; Xiangming Mao; Yun Chen; Yongqing Lai
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

Review 7.  Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.

Authors:  Francesco Piva; Matteo Giulietti; Matteo Santoni; Giulia Occhipinti; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Giovanni Principato; Rodolfo Montironi
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 8.  Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.

Authors:  Karthigayan Shanmugasundaram; Karen Block
Journal:  Antioxid Redox Signal       Date:  2016-07-27       Impact factor: 8.401

Review 9.  [How do metastases of urological tumors develop?].

Authors:  M Rose; R Knüchel
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

Review 10.  Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.

Authors:  Tianying Xing; Huiying He
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.